Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

This grant opportunity (PAR-25-183) from the NIH supports early-stage clinical trials (R33) for pharmacologic or neuromodulatory device-based interventions aimed at treating mental disorders. The funding is available under CFDA 93.242.